New Evidence: Veterinarian-Pharmacist Collaboration

According to Kambayashi et al., PLOS One (2026) PLOS One, the global literature on veterinarian-pharmacist collaboration is limited (16 included studies) but consistent in showing pharmacists most often contribute via compounding and drug information support.

• 239 records were retrieved and screened, and 16 studies were included in the final review, according to Kambayashi et al., PLOS One (2026) (search completed 30 August 2025).
• Kambayashi et al., PLOS One (2026) report that 62.5% of included studies (10 of 16) described pharmacists’ roles in compounding and dispensing, with studies published between 2007 and 2024.
• Kambayashi et al., PLOS One (2026) found geographic concentration: United States (n = 7), New Zealand (n = 3), and Japan (n = 3), with the article published on 31 July 2026.
• Kambayashi et al., PLOS One (2026) identify a persistent barrier described as a perceived "knowledge gap" in species-specific pharmacology that limits deeper clinical integration.

Answer: Kambayashi et al., PLOS One (2026) systematically mapped literature on veterinarian-pharmacist collaboration to describe roles, settings, and perceptions and to identify research gaps.

According to Kambayashi et al., PLOS One (2026), two reviewers searched PubMed, Web of Science, the Cochrane Library, Ichushi-Web, and Google Scholar through 30 August 2025, retrieved 239 records, and after de-duplication and screening included 16 studies published from 2007 to 2024.

According to Kambayashi et al., PLOS One (2026), most included studies were cross-sectional surveys and settings included veterinary hospitals (12 studies), community pharmacies (4 studies), and zoos (3 studies).

According to Kambayashi et al., PLOS One (2026), pharmacist activities reported were: compounding/dispensing (10/16 studies, 62.5%), drug information/consultation (6/16, 37.5%), inventory/supply management (4/16, 25.0%), client education (3/16, 18.8%), and safety/exposure control (2/16, 12.5%).

"Pharmacists are expanding their role in veterinary medicine, evolving from traditional dispensing functions to active contributors to clinical care and medication safety, " write Kambayashi et al., PLOS One (2026).

Answer: The PLOS One review indicates research priorities and educational gaps that researchers and educators should address to build trust and measurable impact.

According to Kambayashi et al., PLOS One (2026), a core barrier is veterinarians' concern about pharmacists' limited species-specific training; this suggests targeted curriculum and residency programs are needed to close the trust gap.

According to Kambayashi et al., PLOS One (2026), most existing evidence is perception-based; researchers should design prospective studies that measure clinical outcomes, medication errors, or occupational safety to move beyond surveys.

According to Kambayashi et al., PLOS One (2026), regional practice differences mean interventions should be context-specific: in North America and Oceania prioritize compounding protocols, in parts of Asia prioritize inventory and information services.

Answer: The 2026 PLOS One scoping review maps a small but actionable literature on veterinarian-pharmacist collaboration and highlights education, research, and contextual pilots as next steps.

According to Kambayashi et al., PLOS One (2026), addressing the perceived species-specific training gap is central to expanding pharmacists' roles from compounding to integrated clinical participation.

Researchers and stakeholders can use AI-enabled qualitative analysis to prioritize interventions, translate non-English evidence, and design measurable pilots that test safety and clinical outcomes.

If you want to synthesize interviews, surveys, and the literature cited in the PLOS One review faster, Try Evidano for free. For tool details see Evidano features.